Association of presence of APLA subtypes, IgG or IgM combined, with thrombotic events; persistent versus persistent or transient antibodies
. | Persistent . | . | Persistent or transient . | . | ||
|---|---|---|---|---|---|---|
| APLA subtype . | OR (95% CI) . | P* . | OR (95% CI) . | P* . | ||
| Lupus anticoagulant | ∞ (6.0-∞) | < .001 | ∞ (3.2-∞) | < .001 | ||
| ACLA: IgG or IgM | 15.7 (2.5-97) | .003 | 2.8 (0.5-16) | .211 | ||
| Anti-β2-GPI: IgG or IgM | 22.0 (2.3-207) | .002 | 12.0 (1.3-110) | .014 | ||
| Anti-PT: IgG or IgM | 4.7 (0.9-25) | .063 | 2.6 (0.5-15) | .243 | ||
. | Persistent . | . | Persistent or transient . | . | ||
|---|---|---|---|---|---|---|
| APLA subtype . | OR (95% CI) . | P* . | OR (95% CI) . | P* . | ||
| Lupus anticoagulant | ∞ (6.0-∞) | < .001 | ∞ (3.2-∞) | < .001 | ||
| ACLA: IgG or IgM | 15.7 (2.5-97) | .003 | 2.8 (0.5-16) | .211 | ||
| Anti-β2-GPI: IgG or IgM | 22.0 (2.3-207) | .002 | 12.0 (1.3-110) | .014 | ||
| Anti-PT: IgG or IgM | 4.7 (0.9-25) | .063 | 2.6 (0.5-15) | .243 | ||
Fisher exact test